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Abstract
Background: The COP9 signalosome (CSN) is a conserved protein complex in eukaryotic cells
consisting of eight subunits (CSN1 to CSN8). Recent data demonstrate that the CSN is a regulator
of the ubiquitin (Ub) proteasome system (UPS). It controls substrate ubiquitination by cullin-RING
Ub ligases (CRLs), a process that determines substrate specificity of the UPS. The intrinsic
deneddylating activity localized to CSN5 as well as the associated kinases and deubiquitinating
activity are involved in the regulatory function of CSN. The exact mechanisms are unclear. In this
study we knocked down CSN1 (siCSN1), CSN3 (siCSN3) and CSN5 (siCSN5) by specific siRNA
oligos permanently expressed in HeLa cells. The analysis and comparison of siRNA cells revealed
differential impact of individual subunits on CSN structure and function.
Results: Permanent knockdowns of CSN1 and CSN3 led to a reduction of the subunits to
approximately 40%, which is accompanied by a proportional decrease of the CSN holocomplex. In
contrast, downregulation of CSN5 in HeLa cells reduced the CSN5 protein below 20% without
significant effects on the remaining complex. The CRL component Rbx1 was characterized by
accelerated proteolysis in siCSN1 and siCSN3 and also in siCSN5 cells, however, with lesser
extent. Immunoprecipitated CSN complex from siCSN5 cells was less effective in phosphorylating
c-Jun and p27. Accelerated degradation of c-Jun in siCSN5 cells was rescued by overexpression of
CSN5 as well as of the deneddylation mutant CSN5D151N. Overexpression of CSN5 cannot
rescue c-Jun destabilization in siCSN1.
Conclusion: There exists a coordinated downregulation of CSN subunits in the CSN1 and CSN3
knockdowns. The underlying regulatory mechanisms are obscure. CSN5 seems to possess a
specific status in HeLa cells. Its reduction is not connected with coordinated downregulation of
other subunits. CSN knockdowns confirm that the stabilization of the CRL component Rbx1 is a
major CSN function. In addition, downregulation of CSN subunits influences the stability of
important cellular regulators such as c-Jun and p27.
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Background
The COP9 signalosome (CSN) is a conserved protein
complex, which controls eukaryotic protein degradation
via the ubiquitin (Ub) proteasome system (UPS) [1,2]. In
mammals the core complex consists of 8 subunits (CSN1
to CSN8) [3], the exact function of which is not exactly
known. CSN5 exhibits a MPN+/JAMM domain [4,5]
responsible for metalloprotease activity. As a complex-
bound protein CSN5 removes NEDD8, an ubiquitin-like
protein, from cullins. This cleavage of an isopeptide bond
called deneddylation controls the ubiquitination by cul-
lin-RING Ub ligases (CRLs), a large family of multisubu-
nit E3s [6,7]. Cullin proteins (Cul1 to Cul7) are
components of CRLs functioning as scaffolds of the Ub
ligase complexes. Cullin neddylation and deneddylation
regulates the CRL complex assembly in a substrate
dependent manner as it has been shown for Cul1-SCFSkp2
and p27Kip (p27) [8]. In addition, CRLs contain RING-
domain proteins, frequently Rbx1 or Rbx2, which are
responsible for ubiquitination as well as for neddylation
[9]. Substrate specificity of the CRLs is determined by
components called substrate receptors including F-box
proteins in Cul1-based CRLs and BTB-domain proteins in
Cul3-complexes [7].
The CSN is associated with a cysteine protease called Ub
specific protease 15 (USP15), which belongs to the family
of deubiquitinating enzymes (DUBs) [10,11]. USP15 is
able to cleave linear as well as branched Ub chains. The
cleavage of lysine 48-linked poly-Ub chains requires a
functional Zn finger [10]. The cysteine protease regulates
the activity of CRLs by protecting Rbx1 [10] as well as F-
box and BTB-domain proteins [11,12] from autoubiquiti-
nation and degradation.
In addition, the CSN is associated with kinases such as
CK2, PKD [13], Akt [14] and inositol 1,3,4-trisphosphate
5/6 kinase [15]. The kinases modify substrates of the UPS
and determine their stability [1]. The CK2 binds to subu-
nits CSN3 and CSN7 whereas the PKD interacts with
CSN3 [13]. CSN-associated CK2 phosphorylates the
tumor suppressor p53 [16] and the inhibitor of cyclin-
dependent kinases p27 [14], which targets the proteins to
degradation by the 26S proteasome. In contrast, phospho-
rylation of c-Jun stabilizes the transcription factor towards
the UPS [13,17]. Inhibitors of CSN-associated kinases
such as curcumin or emodin elevate the amount of p53,
which causes apoptosis in tumor cells [18]. On the other
hand, by blocking phosphorylation these compounds tar-
get c-Jun to rapid degradation by the UPS [13,18]. Subunit
CSN5 directly interacts with c-Jun [19], p27 [20] as well as
with p53 [16], which is presumably necessary for CSN-
mediated phosphorylation and degradation of the pro-
teins, although the exact interrelations are not yet clear.
The impact of permanent downregulation of CSN5 in
HeLa cells on the stability of c-Jun and p27 was investi-
gated in the present study.
To analyze functional characteristics of genes in yeast,
knockouts have been performed. Unfortunately knock-
outs of CSN genes in yeast possess only weak or no phe-
notypes [21]. In contrast, CSN knockouts in Drosophila
[22], in plants [2,23] and in mammals [24,25] are lethal.
Recently functional genomic studies in mammalian cells
include specific siRNA oligos that cause degradation of
the target gene mRNAs. For example, the conditional
knockdown of CSN5 expression in HEK293 cells using a
doxycycline-inducible shRNA system led to the degrada-
tion of F-box proteins accompanied with reduced CRL
activity [26]. It has been shown that downregulation of
Jab1/CSN5 in leukemia cell lines prevented p27 degrada-
tion [27]. Recent knockdown studies in Drosophila
revealed a role of the CSN in the cell cycle [28].
By using specific siRNA oligos against CSN1, CSN3 and
CSN5 permanently expressed in HeLa cells, we studied the
impact of CSN subunit knockdowns on the CSN complex
stability and target protein degradation. We demonstrate
that knockdowns of CSN1 or CSN3 led to a downregula-
tion of the entire CSN complex, whereas in case of CSN5
downregulation the remaining complex was stable. The
decrease of the binding subunit CSN5 in siCSN5 cells as
well as diminished CSN complex in siCSN1 and siCSN3
cells led to reduced stability of Rbx1 and c-Jun, whereas
p27 was stabilized in siCSN1 cells.
Results
The CSN5 knockdown is unique compared to CSN1 or 
CSN3 knockdowns in HeLa cells
In order to study the influence of individual subunits on
CSN composition and functions CSN1, CSN3 as well as
CSN5 were downregulated by specific siRNA oligos per-
manently expressed in HeLa cells. As a control HeLa cells
permanently expressing siRNA oligos against GFP (siGFP)
were used. Fig. 1a demonstrates the impact of siRNA oli-
gos against CSN1 (siCSN1), CSN3 (siCSN3) and CSN5
(siCSN5) on the protein levels of the corresponding CSN
subunits in HeLa cells. The Western blot shows that
downregulation of CSN1 and CSN3 is accompanied by a
reduction of subunits CSN5 and CSN8. As it has been
shown earlier under these conditions CSN1 and CSN3
protein levels were reduced below 40%, which was paral-
leled by a similar reduction of the holocomplex [29]. In
contrast, downregulation of CSN5 below 20% had little
effect on the stability of CSN8. Non-denaturing gel elec-
trophoresis and glycerol gradient centrifugation revealed
that siCSN5 cells possessed CSN complexes with less or
no CSN5 as compared to control cells (Fig. 1b and 1c). In
native gels the CSN migrated to the same position as the
control holocomplex, however, exhibiting only aboutBMC Biochemistry 2007, 8:27 http://www.biomedcentral.com/1471-2091/8/27
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Comparison of HeLa cells permanently expressing siRNA oligos against CSN1, CSN3 or CSN5 Figure 1
Comparison of HeLa cells permanently expressing siRNA oligos against CSN1, CSN3 or CSN5. (a) Western blots with 
lysates from HeLa cells permanently expressing siRNA oligos against GFP (siGFP cells = control cells), CSN1 (siCSN1 cells), CSN3 
(siCSN3 cells) and CSN5 (siCSN5 cells) were performed using the anti-CSN5 and the anti-CSN8 antibody. RPN2 was analyzed as a load-
ing control. The signals obtained with the anti-CSN5 and the anti-CSN8 antibodies were evaluated by densitometry. Values obtained in 
control cells were put to 100%. Similar blots with anti-CSN1 and anti-CSN3 antibodies were published recently [29]. 20S indicates the 
position of the 20S proteasome in the non-denaturing gels under our conditions. (b) Non-denaturing gel electrophoresis and blot with 
lysates from control cells (siGFP) and siCSN5 cells using the Phast-gel system. The same blot was probed with the anti-CSN5 antibody 
and the anti-CSN8 antibody. Whereas the anti-CSN5 antibody revealed a reduction to 23% as compared to the control, there was no 
decrease of the CSN complex observed with the anti-CSN8 antibody. (c) Glycerol gradient centrifugation of lysates from siGFP and 
siCSN5 cells. Aliquots of fractions 1 to 19 were probed by Western blotting using the anti-CSN5 and the anti-CSN8 antibody. Under 
these conditions the CSN complex sedimented into fractions 9 to 13. Free subunits were not detected. Under these conditions the 20S 
proteasome sedimented into fraction 5 to 9. (d) Control cells (siGFP) and siCSN5 cells were transfected with Flag-CSN5wt. The upper 
panels demonstrate Western blots with the anti-Cul1 antibody demonstrating two bands, deneddylated and mono-neddylated Cul1. 
There was significantly more mono-neddylated Cul1 in siCSN5 cells (vector) as compared to siGFP cells. Deneddylation was restored by 
overexpression of CSN5. The lower panel shows Western blots with the anti-CSN5 antibody visualizing the endogenous and the Flag-
tagged exogenous CSN5 protein.BMC Biochemistry 2007, 8:27 http://www.biomedcentral.com/1471-2091/8/27
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20% of the wild type (wt) CSN5 content (Fig. 1b). In glyc-
erol gradients performed with lysate from siCSN5 cells the
CSN5 protein was hardly detectable in all fractions
whereas the CSN8 protein was not significantly changed
in the common CSN fractions (Fig. 1c). These data indi-
cated that the knockdown of CSN5 had little impact on
the total amount and the size of the CSN in HeLa cells.
This differs from CSN1 or CSN3 knockdowns where the
amount of the CSN holocomplex decreased proportion-
ally to the reduction of the CSN subunits [29]. In siCSN5
cells deneddylation of Cul1 was reduced compared to the
control with siGFP cells (see Fig. 1d). There was an
increase in mono-neddylated Cul1 as indicated by the
Western blot. This effect could be reversed by overexpress-
ing CSN5wt into siCSN5 cells. As shown in Fig. 1d, dened-
dylation of Cul1 was restored by exogenous CSN5
indicating that the subunit was integrated into the com-
plex.
CSN knockdowns destabilize the RING-domain protein 
Rbx1
It has been shown before that the CSN, most likely by the
CSN-associated deubiquitinating enzyme USP15, protects
components of CRLs including the CRL RING-domain
component, Rbx1, against autoubiquitination and degra-
dation [10,12]. Therefore, by cycloheximide chase (CHX)
experiments we investigated whether downregulation of
CSN subunits has any influence on the stability of Rbx1.
As shown in Fig. 2a and 2b, in siCSN1, siCSN3 as well as
in siCSN5 cells Rbx1 was degraded faster as compared to
the control. However, as demonstrated by densitometric
analysis the CSN5 knockdown was significantly less effec-
tive in stimulating Rbx1 proteolysis as compared to CSN1
and CSN3 knockdowns (Fig. 2b).
There are differential roles of CSN subunits in affecting 
target protein stability
The deneddylating MPN+-domain protein CSN5 interacts
with a large number of ligands. It can be called a substrate
receptor of CSN interacting proteins including important
regulators such as c-Jun and p27 (for rev. see [1]). In con-
trast, CSN1 and CSN3 interact with CSN-associated
kinases [13,15]. One might postulate that knockdowns of
CSN1, CSN3 and CSN5 should cause reduced CSN-medi-
ated phosphorylation of c-Jun and of p27, however, due
to different reasons.
C-Jun is stabilized by CSN-mediated phosphorylation
towards the UPS [13]. To see whether c-Jun stability is
changed in siCSN1, siCSN3 and in siCSN5 cells, we meas-
ured the proteolysis of the transcription factor in CHX
experiments. We expected an accelerated degradation in
HeLa cells with downregulated CSN subunits. As shown
in Fig. 3a, c-Jun degradation is significantly faster in
siCSN1, siCSN3 as well as in siCSN5 cells as compared to
the control. The half-life of c-Jun declined from approxi-
mately 40 min in the control down to 20 min in CSN1
knockdown cells. The changes in siCSN5 cells might be
the result of the reduced CSN5 substrate receptor, which
is necessary for c-Jun binding and subsequent phosphor-
ylation. To prove this hypothesis siCSN5 cells were trans-
fected with CSN5wt as in Fig. 1d. As shown in Fig. 3b, left
panel, overexpression of CSN5wt increases c-Jun half-life
to a level, which is similar to that in siGFP cells (Fig. 3a,
upper left panel). Then we asked whether the deneddylat-
ing activity of CSN5 is necessary for c-Jun stabilization.
For this purpose the CSN5D151N mutant, which lost its
metalloprotease activity, was transfected into siCSN5
cells. As seen in Fig. 3b, right panel, overexpression of the
CSN5D151N mutant rescued c-Jun just like CSN5wt,
indicating that the mutant supports binding of c-Jun to
the CSN and perhaps subsequent phosphorylation. In
siCSN1 and in siCSN3 cells overexpression of CSN5wt
should not block accelerated degradation of c-Jun. This
was tested with siCSN1 cells and is shown in Fig. 3c.
To analyze whether cellular CSN lost its ability to phos-
phorylate c-Jun or p27 in siCSN5 cells, the CSN was
immunoprecipitated from siGFP and siCSN5 cells with
the anti-CSN7 antibody and kinase assays were performed
with the precipitates. As shown in Fig. 4a, autophosphor-
ylation of CSN2 and of CSN7 was detected indicating that
the CSN-associated kinases precipitated from siCSN5 cells
were active. It seemed that overall phosphorylation was
slightly reduced, although autophosphorylation of CSN2
increased. The phosphorylation of recombinant c-Jun was
diminished by more than 50% with the precipitate from
siCSN5 cells as compared with the control (Fig. 4b). The
effect is even more obvious with recombinant p27.
Almost no phosphorylation was observed with the immu-
noprecipitate from siCSN5 cells (Fig. 4c).
The above data indicate that downregulation of CSN5 led
to a reduced phosphorylation of c-Jun by the immunopre-
cipitated CSN (Fig. 4b), which correlated with an acceler-
ated degradation of the transcription factor (Fig. 3a).
Since CSN-mediated phosphorylation of p27 accelerates
its degradation by the UPS [14], we expected a stabiliza-
tion of p27 in cells with CSN subunit knockdowns. There-
fore, siCSN1 cells were synchronized by serum-
deprivation for 24 h and then driven into G1 phase of cell
cycle by serum complementation as performed before
[14]. As seen in Fig. 5a, there is a significant stabilization
of p27 after serum starvation (0 h) in the cytoplasm as
compared to the control, which is most likely due to a
reduced degradation in siCSN1 cells during starvation.
Ten hours after reentry into the G1 phase the cell cycle
inhibitor was still detectable in siCSN1 cells, whereas it
disappeared in siGFP cells.BMC Biochemistry 2007, 8:27 http://www.biomedcentral.com/1471-2091/8/27
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A decreased phosphorylation in siCSN1 cells has been
shown for the microtubule-end-binding protein 1 (EB1)
[29]. Just like c-Jun the protein binds to CSN5 and is sta-
bilized by CSN-mediated phosphorylation. By in vitro
pulldowns with purified CSN and recombinant GST-EB1
and by adding increasing amounts of recombinant CSN5
it was demonstrated that EB1 can be competed away from
its CSN5 binding site (Fig. 5b). A similar experiment was
performed in cells. CSN5wt or CSN5D151N mutant was
overexpressed in HeLa cells and the binding and phos-
phorylation of endogenous EB1 to the CSN was indirectly
estimated by EB1 stability. As seen in Fig. 5c, overexpres-
sion of CSN5wt led to an accelerated degradation of EB1,
most likely because it was competed away from the CSN
and was less phosphorylated. The same effect was
obtained by overexpressing CSN5D151N indicating that
the metalloprotease activity of CSN5 is not necessary for
this competition.
Discussion
In the present study we compared the effects of CSN sub-
unit downregulation on the structure and functions of the
holocomplex. The data presented here as well as in our
recent work on EB1 [29] demonstrate that downregula-
The CRL component Rbx1 is destabilized in CSN knockdown cells Figure 2
The CRL component Rbx1 is destabilized in CSN knockdown cells. (a) CHX chase experiments were performed with siGFP, 
siCSN1, siCSN3 and siCSN5 cells. After the indicated time cell lysates were analyzed by Western blotting using the anti-Rbx1 antibody. 
The α6 proteasomal subunit was probed as loading control. (b) Densitometric analysis of the Rbx1 signals from (a). The densitometric 
signal at 0 h was put to 100% and the percentage of Rbx1 signals was plotted against the indicated time.BMC Biochemistry 2007, 8:27 http://www.biomedcentral.com/1471-2091/8/27
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tion of CSN1 and CSN3 by specific siRNA oligos perma-
nently expressed in HeLa cells led to a proportional
downregulation of the CSN holocomplex. In other words,
knockdowns of CSN1 and CSN3 cause a proportional
reduction of all determined CSN subunits paralleled by a
decrease of the holocomplex. None of the CSN subunits
were detected as free proteins under these conditions.
Similar data were obtained by Kato and co-workers in
murine embryonic fibroblasts were a reduction in the
level of CSN3 protein with siRNA decreased the total
amount of the holocomplex [30]. The complete deletion
of the CSN3 subunit in mice and also in other higher
eukaryotes is lethal, which presumably can be due to the
complete disappearance of the CSN complex [24]. These
The degradation of c-Jun is accelerated in CSN knockdown cells Figure 3
The degradation of c-Jun is accelerated in CSN knockdown cells. (a) CHX chase experiments were performed with siGFP, 
siCSN1, siCSN3 and siCSN5 cells. After indicated time aliquots of cell lysates were analyzed by Western blotting using the anti-c-Jun anti-
body. The same samples were probed with the antibody against the 26S proteasome base subunit RPN2/S1 as a loading control. (b) 
CSN5 knockdown cells were transfected with CSN5wt as in Fig. 1d or with CSN5D151N and 24 h after transfection CHX chase experi-
ments were carried out as in (a). The middle panel shows Western blots with the anti-Flag antibody visualizing the expressed CSN5wt or 
CSN5D151N proteins (c) CSN5wt was overexpressed in siCSN1 cells and after 24 h CHX experiments were performed as in (a). In all 
CHX experiments a band just above c-Jun appeared after 20 – 30 min, which cross-reacted with the anti-c-Jun antibody (in some blots it 
was cut off). This protein might be a modified c-Jun. The nature of this modification is currently unknown. Both the putative modified c-
Jun as well as unmodified c-Jun disappeared during the experiment.BMC Biochemistry 2007, 8:27 http://www.biomedcentral.com/1471-2091/8/27
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data indicate that in mammalian cells exists a coordinated
up and down regulation of CSN subunits accompanied by
an assembly or disassembly process of the holocomplex.
On the contrary, downregulation of subunit CSN5 had lit-
tle or no effect on other CSN subunits and did not lead to
the proportional disappearance of the residual complex.
Similar effects were observed by downregulation of CSN5
in Drosophila as well as in HeLa cells [31,32]. In other
words, in siCSN5 cells CSN complexes possess less or no
CSN5. This might indicate that CSN5 has a different
impact on the coordinated assembly of the CSN as com-
pared to CSN1 and CSN3. On the other hand, a complete
depletion of CSN5 in Arabidopsis resulted in CSN instabil-
ity and the decay of various CSN components [33]. Inter-
estingly, overexpressed CSN5wt is most likely integrated
Phosphorylation of c-Jun and p27 by the CSN immunoprecipitated from siCSN5 cells Figure 4
Phosphorylation of c-Jun and p27 by the CSN immunoprecipitated from siCSN5 cells. (a) Autophosphorylation of CSN sub-
units CSN2 and CSN7 with CSN immunoprecipitates from control cells (siGFP) and from siCSN5 cells. The CSN was precipitated with 
the anti-CSN7 antibody. The immunoprecipitate was incubated with 32P-γ-ATP, separated by SDS-PAGE and the dried gel was exposed 
to X-ray films. The autoradiography shows phosphorylation of CSN2 and CSN7 in the precipitate from siGFP as well as siCSN5 cells. 
Although same numbers of cells were used and the amount of the CSN complex is almost identical in control and siCSN cells, there was 
a slight increase of CSN2 and a decrease of CSN7 and overall phosphorylation with the CSN from siCSN5 cells. The exact reasons for 
these differences are not known at the moment. (b) Immunoprecipitates from siGFP or siCSN5 cells were used to phosphorylate c-Jun. 
The upper panel shows the phosphorylation of c-Jun by autoradiography demonstrating a decrease of c-Jun phosphorylation by more than 
50% as estimated by densitometry. In the middle panel aliquots were analyzed by Western blotting using the anti-CSN3 antibody to con-
trol that equal amounts of the CSN were immunoprecipitated. The lower panel shows the Coomassie stain of c-Jun indicating that the 
same amounts of the protein were used for kinase assays. (c) The same experiments as performed with c-Jun (see b) were carried out 
with p27. As seen in the autoradiography the phosphorylation of p27 is significantly reduced with the CSN from siCSN5 cells as com-
pared to the control.BMC Biochemistry 2007, 8:27 http://www.biomedcentral.com/1471-2091/8/27
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into the CSN complex in siCSN5 cells, because it is able to
restore deneddylation activity of the particle (see Fig. 1d).
Although CSN1, CSN3 as well as CSN5 knockdowns led
to destabilization of Rbx1, the effects are different.
Whereas in siCSN1 and siCSN3 cells Rbx1 degradation is
significantly accelerated, in siCSN5 cells the RING-
domain protein is less destabilized (see Fig. 2). The pro-
tection of Rbx1 from autoubiquitination and degradation
is mostly due to the associated deubiquitinating enzyme
USP15, which interacts predominantly via CSN7 with the
CSN [10]. This might explain why the stability of Rbx1 in
siCSN5 cells is less affected as compared to siCSN1 or
siCSN3 cells. Our siRNA studies confirm the hypothesis
that the CSN stabilizes CRL components by protecting
them against autoubiquitination [10,12]. With less CSN
Binding of p27 and of EB1 to the CSN determines the stability of the two cellular regulators Figure 5
Binding of p27 and of EB1 to the CSN determines the stability of the two cellular regulators. (a) Steady state levels of p27 
were determined by Western blotting in siCSN1 and siGFP HeLa cells, which were synchronized as described before [14]. After reentry 
into G1 phase Western blots were performed with aliquots from the cytoplasm obtained after 0, 4 and 10 h. The cytoplasmic fraction 
was prepared as described using SOS protein as a marker for the cytoplasm [14]. As a loading control β-tubulin was analyzed. At the 
beginning of G1 phase the cell cycle inhibitor p27 was stabilized in the cytoplasm of CSN1 knockdown cells as compared to control cells 
(siGFP). (b) Purified CSN, recombinant GST-EB1 and increasing amounts of recombinant His-CSN5 were incubated for 30 min at 37°C. 
After incubation the mixture was directly analyzed by Western blotting (Input) or GST-pulldowns were performed and the precipitates 
were probed by anti-EB1 and anti-CSN3 antibodies. With increasing amounts of His-CSN5 less CSN complex was pulled down with 
GST-EB1 indicating that the binding between EB1 and the CSN was disturbed by CSN5. (c) The impact of the overexpression of CSN5wt 
or CSN5D151N mutant on EB1 steady state levels in HeLa cells. Transfection with the empty vector was used as control. Cells were 
lyzed 24 h after transfection and aliquots were analyzed by Western blotting using the anti-EB1 antibody (upper panel). The same lysates 
were tested with the anti-CSN5 antibody showing the endogenous and the Flag-tagged exogenous CSN5 protein (middle panel). The pro-
teasome subunit RPN2/S1 was probed as a loading control (lower panel).BMC Biochemistry 2007, 8:27 http://www.biomedcentral.com/1471-2091/8/27
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and its associated USP15 in cells there is less protection of
the CRLs.
We speculate that changed stabilities of c-Jun, p27 and
EB1 in siCSN1, siCSN3 as well as siCSN5 cells can be due
to reduced CSN-mediated phosphorylation of these pro-
teins. In siCSN1 and siCSN3 cells the amount of the CSN
platform itself together with its associated kinases was
decreased. In CSN5 knockdown cells the reduction of the
substrate receptor CSN5 might be sufficient to cause a
diminished phosphorylation of the tested substrates (see
Fig. 4). Immunoprecipitated CSN from siCSN5 cells was
less efficient in phosphorylating c-Jun as well as p27 as
compared to the control. This effect can be explained by
the reduction of CSN5 and, at least in part, by reduced
overall kinase activity (see Fig. 4a) perhaps caused by a
changed CSN structure. In contrast to siCSN1 cells the
accelerated degradation of c-Jun in siCSN5 cells was
blocked by overexpression of CSN5wt as well as of
CSN5D151N mutant (see Fig. 3). Based on these data we
came to two conclusions. (i) The overexpressed CSN5wt
was integrated into CSN5-deficient CSN complexes and
acts as substrate receptor allowing normal substrate phos-
phorylation. (ii) The rescue of c-Jun stability by overex-
pressing CSN5D151N demonstrates that the mutant is as
potent as the CSN5wt indicating that the metalloprotease
activity of CSN5 was not responsible for the effect.
Presumably reduced phosphorylation of p27 in CSN
knockdown cells resulted in a stabilization of the cell cycle
inhibitor during serum starvation (see Fig. 5a). Thus, the
CSN might control the ubiquitination of p27 by two dif-
ferent activities. First, it regulates the assembly of the
appropriate Cul1-CRL complex for p27 ubiquitination by
deneddylation [8]. Second, it seems to be a platform for
p27 phosphorylation that most likely accelerates p27
ubiquitination.
Our data also show that one should be cautioned with the
overexpression of CSN5. In HeLa cells free CSN5 is unde-
tectable under our conditions. Overexpression of CSN5
produces a free CSN5 protein pool, which stimulates the
degradation of EB1. As shown by competition experi-
ments in Fig. 5b and 5c, this is most likely due to the trap-
ping of EB1 by free CSN5 and, as a result, to reduced CSN-
mediated phosphorylation and destabilization of EB1.
We speculate that overexpression of CSN5 might exert
artificial effects on other substrates that interact with
CSN5 as well.
Future knockdown experiments with other CSN subunits
are necessary to fully understand the relationship between
structure and function of the CSN complex. In addition,
the integration of diverse mutated subunits into the CSN
complex where possible will elucidate specific functions
of subunit domains.
Conclusion
We have shown that downregulation of CSN1 and CSN3
reduced the CSN holocomplex. In contrast, downregula-
tion of CSN5 did not change the remaining CSN complex,
although CSN5 protein was reduced. All studied knock-
down cells were characterized by a destabilization of the
CRL component Rbx1 and of the transcription factor c-
Jun. In CSN5 knockdowns c-Jun destabilization was res-
cued by CSN5 overexpression, demonstrating the sub-
strate receptor role of CSN5.
Methods
Preparation of the CSN, cell culture and siRNA knockdown 
of CSN subunits
The human CSN complex was purified from red blood
cells as outlined in detail [34]. HeLa cells were cultured as
described previously [16]. siRNA-mediated knockdown of
CSN1 and CSN3 was performed as outlined recently [29]
using the pSUPER system. The knockdown of CSN5 was
performed with the target sequences published by
Groisman and co-workers [32]. Synchronization of HeLa
cells was carried out as described previously [14].
Transfection of HeLa cells, site directed mutagenesis and 
CHX chase experiments
HeLa cells were transfected with Lipofectamine2000 (Inv-
itrogen) according to the manufacturers recommenda-
tions. The metalloprotease mutant CSN5D151N was
created by site directed mutagenesis as outlined before
[10]. Expression of Flag-CSN5 and of Flag-CSN5D151N
in HeLa cells was performed as described before [17]. Res-
cue experiments of c-Jun degradation were performed
after transfection with 2.5 μg of CSN5wt DNA or 5 μg of
CSN5D151N DNA. CHX chases were carried out at a final
concentration of 20 μg/ml CHX as in [29].
Immunoprecipitation, kinase assays, Western blotting, 
competition experiments and glycerol gradients
Immunprecipitations and glycerol gradient centrifuga-
tions were performed as described [29]. The in vitro kinase
assays were carried out as outlined previously [13]. SDS-
PAGE, Western blotting and ECL detection (GE Health-
care) were performed by standard procedures. Non-dena-
turing electrophoresis was carried out using the Phast-
System (GE Healthcare). Competition experiments with
EB1, CSN5 and the CSN complex were performed as
described [29] using recombinant GST-EB1, recombinant
His-CSN5 and purified CSN. In this study the following
antibodies were used: Anti-CSN5 (provided by B.
Christy), anti-Rbx1 (Zymed), anti-CSN8 (Biomol), anti-α
6 and anti-RPN2 (provided by C. Hendil), anti-c-Jun
(Upstate), anti-p27 and anti-EB1 (Santa-Cruz), anti-β-BMC Biochemistry 2007, 8:27 http://www.biomedcentral.com/1471-2091/8/27
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tubulin (Covance), anti-CSN3 antibodies [35] and anti-
Flag (Sigma).
List of abbreviations
CSN: COP9 signalosome
Ub: ubiquitin
UPS: ubiquitin proteasome system
CRL: cullin-RING ubiquitin ligases
p27Kip: p27
CHX: cycloheximide
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